# Yuyo Llamazares Vegh

> Yuyo Llamazares Vegh is the CEO and Co-Founder of Stämm, a San Francisco-based biotech company reinventing biomanufacturing through miniaturized 3D-printed microfluidic bioreactors. A native of Argentina with a background in agricultural engineering and bioprocesses from the University of Buenos Aires, Yuyo co-founded Stämm in 2016 alongside his cousin Federico D'Alvia Vegh after spotting a fundamental gap between biology's potential and the outdated tools available to harness it. Stämm's platform - desktop-sized, modular, and scalable - is designed to make the production of biologics, cell therapies, and gene therapies accessible and repeatable at any scale. The company has raised over $17 million including a Series A led by Varana Capital with participation from Draper Associates and SOSV's IndieBio, and has attracted former Merck KGaA CEO Stefan Oschmann to its board. Yuyo was selected as an Endeavor Entrepreneur in 2023.

- **Role:** CEO & Co-Founder at Stämm
- **Organizations:** Stämm, IndieBio (SOSV), Singularity University, Endeavor
- **From:** Argentina
- **Nationality:** Argentine
- **Education:** Agricultural Engineering, specialization in Phytopathology and Bioprocesses, University of Buenos Aires, Global Solutions Program, Singularity University, Biotech Accelerator - Cohort 7, IndieBio (SOSV)
- **Known for:** Co-founded Stämm in 2016, pioneering microfluidic-based continuous biomanufacturing, Raised over $17 million in Series A funding from top-tier investors including Draper Associates, Accepted into IndieBio (SOSV) Cohort 7 - one of the world's top biotech accelerators

## Career timeline

- **2007** — Began studying Agricultural Engineering at the University of Buenos Aires
- **2016** — Co-founded Stämm Biotech with cousin Federico D'Alvia Vegh in Argentina
- **2016** — Selected for Singularity University Global Solutions Program
- **2018** — Stämm accepted into IndieBio (SOSV) Cohort 7 biotech accelerator in San Francisco
- **2022** — Closed $17M Series A round led by Varana Capital, with Draper Associates and SOSV
- **2023** — Selected as Endeavor Entrepreneur by Endeavor Argentina network
- **2023** — Stefan Oschmann (former CEO of Merck KGaA) appointed to Stämm board
- **2026** — Launched High-Throughput Bioprocessor (HTB) - bubble-free, automated biomanufacturing platform

## Achievements

- Co-founded Stämm in 2016, pioneering microfluidic-based continuous biomanufacturing
- Raised over $17 million in Series A funding from top-tier investors including Draper Associates
- Accepted into IndieBio (SOSV) Cohort 7 - one of the world's top biotech accelerators
- Selected as Endeavor Entrepreneur in 2023 - joining a network that includes Marcos Galperin and Globant founders
- Attracted former Merck KGaA CEO Stefan Oschmann to join Stämm's board
- Developed first methodology for continuous industrial biological production using microfluidics and 3D printing
- Expanded Stämm from Argentina to San Francisco and Switzerland
- Launched the High-Throughput Bioprocessor (HTB) in 2026 for decentralized biomanufacturing

## Latest updates

- **2026-03** — Stämm launched the High-Throughput Bioprocessor (HTB), a bubble-free automated biomanufacturing platform designed for decentralized production of biologics and cell therapies
- **2023-07** — Stefan Oschmann, former CEO and Chairman of Merck KGaA, appointed as Independent Director to Stämm's board
- **2023-04** — Yuyo selected as Endeavor Entrepreneur by Endeavor Argentina, joining the global Endeavor network

## Links

- Website: https://stamm.bio
- LinkedIn: http://www.linkedin.com/in/yuyo-llamazares-vegh-42221164
- Twitter/X: https://twitter.com/__yuyo
- Instagram: https://www.instagram.com/yuyollamazares/

---

Profile page: https://yespress.io/yuyo-llamazares-vegh
Published by YesPress — https://yespress.io
Last updated: 2026-05-20